Mallinckrodt reaches settlement in mammoth opioid lawsuit

Ireland-based Mallinckrodt Pharmaceuticals makes 90% of its sales from the US and is one of the largest manufacturers of generic opioids. It proposed to pay 2 Ohio counties $24million in cash and donate $6million in drugs, including addiction treatment medications, to take it off the list of defendants facing a test case on the prescription opioid epidemic.